Call (888) 973-6379

Invokana Lawsuit

Invokana (canagliflozin) is a type 2 diabetes treatment designed to help lower blood sugar. Approved in March 2013 by the FDA, the blockbuster medication has brought in for Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, an estimated $1 billion in annual sales. However, since Invokana’s entry to the market, some patients have reported severe side effects such as kidney failure, heart attacks, strokes, and increased blood acid levels, or ketoacidosis. Symptoms of ketoacidosis include difficulty breathing, nausea, vomiting, abdominal pain, confusion, and unusual fatigue. Lawsuits have been filed against Janssen and Johnson & Johnson regarding Invokana, alleging that the manufacturers failed to properly study the drug’s effects and adequately warn patients of its dangerous risks.

Free Case Evaluation

If you or a loved one are affected by complications resulting from the drug Invokana, contact us by calling

(888) 973-6379

or by filling out this form so we can discuss the legal options available to you. Fields marked with * are required.

You havecharacters left.
captcha
Web Analytics